Atlas Trials

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Clinical trial NCT01592773 · TERMINATED

Trial details

NCT number
NCT01592773
Sponsor
Forest Laboratories
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum Disorder (ASD)AutismAutistic DisorderAsperger's DisorderAsperger'sPediatric AutismPervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Start date
2012-10-01
Primary completion
2014-01-01
Enrollment
747

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.